Revenue Exceeds Expectations
Q3 2025 revenue was $17.3 million, significantly above the guidance range of $15.1 million to $15.6 million, marking the sixth consecutive quarter of growth.
Strong Gross Margin
GAAP gross margin for Q3 2025 was 63%, better than the guidance range and consistent with Q2 2025.
ProEV Segment Growth
Adoption of the VF3000 chipset continued to grow, emphasizing demand in the ProEV market.
Medical Innovations
Launch of the first V7000-based disposable colonoscopy with 4K video resolution, showcasing strong market fit and addressing industry trends.
Automotive Sector Developments
Multiple design wins with leading European OEMs for the MiPi A5 standard, strengthening the company's position in the automotive market.